1. DNA flow cytometric analysis and prognosis of axillary lymph node-negative breast carcinoma;Bosari, S.; Lee, A.K.C.; Tahan, SR, Figoni; MAT, Wiley; BD, Heatley; G.J.;Cancer,1992
2. Prediction of relapse or survival in patients with node-negative breast cancer by DNA flow cytometry;Clark, G.M.; Dressler, L.G.; Owens, M.A.; Pounds, G.; Oldakker, T.; McGuire, W.L.;NEnglJMed,1989
3. DNA ploidy and survival in breast cancer patients;Cornelisse, C.J.; van de CJH, Velde; Caspers, R.J.C.; Moolenaar, A.J.; Hermans, J.;Cytometry,1987
4. DNA flow cytometric analysis of primary operable breast cancer;Fisher, B.; Gunduz, N.; Costantino, J.; Fisher, E.R.; Redmond, C.; Mamounas, E.P.;Cancer,1991
5. DNA index and S-phase fraction and their combination as prognostic factors in operabel ductal breast carcinoma;Joensuu, H.; Toikkanen, S.; Klemi, P.J.;Cancer,1990